With manufacturers now stockpiling medicines and potential border delays between the EU and UK looking likely, the uncertainty surrounding Brexit is causing a lot of consternation. To gain a global perspective, Reece Armstrong sits down with Dr Paul Peter Tak, a venture partner at Flagship Pioneering and the former senior vice president of R&D, development leader and chief immunology officer at GSK, to gain a global perspective on Brexit and pharma.
Dr Paul Peter Tak
Hailing from the Netherlands, Dr Tak’s involvement in life sciences is well regarded. A professor of medicine, Dr Tak is also on the board of directors at two biotech companies based in the UK, and his work at Flagship Pioneering helps create new biotech companies in Cambridge, Massachusetts (US).